1 rich Libsyn https://www.libsyn.com 300 600 🫀 Residual Risk in Coronary Artery Disease Even after “optimal” therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it’s thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert. &amp;nbsp; This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes. &amp;nbsp; 📊 Key message: precision, not complacency. #Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine Dr. RR Baliga's 'Podkast for the Kurious Doc' http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39988220/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/198207820